![logo_FFI 3 [Converti]-01 (2).png](https://static.wixstatic.com/media/53e054_041587289b8b42d6905bf46a926209a8~mv2.png/v1/fill/w_129,h_153,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/logo_FFI%203%20%5BConverti%5D-01%20(2).png){kind=logo}
Symposium
“Shaping the Future in
Psychiatry & Mental Health”
Date and Venue
November 4, 2026
Carlton Hotel
Tel Aviv, Israel
The Fondation France-Israël is organizing a French-Israeli symposium in Tel Aviv, bringing together leading researchers, physicians, entrepreneurs, and innovation experts to explore the new frontiers of psychiatry and mental health.
Immuno-psychiatry, artificial intelligence and digital tools, new therapeutic approaches, neuromodulation, and post-traumatic stress care: French and Israeli experts will share their research and practices to identify new approaches to better diagnose, prevent, and treat psychiatric disorders.
But the ambition of the symposium goes beyond sharing knowledge: part of the program will be dedicated to working sessions designed to foster new collaborative projects between French and Israeli teams.
This symposium will be held in English.
This symposium is coordinated by the Foundation in collaboration with the Embassy of France in Israel, the French Institute of Israel, Expertise France, FondaMental Foundation, the PROPSY Precision Psychiatry Exploratory Research Program, Clalit, BrainsWay, Tel Aviv University, and Business France.
Free registration is required
A fee of 120 shekels (₪) will be charged to participants wishing to have lunch at the hotel
Program
08:00 – 08:30 Welcome Coffee
08:30 – 08:45 Opening Remarks
FRANCE
H.E. Christophe Parisot — French Ambassador to Israel
ISRAEL
CEO, Clalit Healthcare Services — (TBC)
CEO, Brainsway
08:45 – 09:15 Keynotes — France / Israel
FRANCE
Prof. Marion Leboyer — Professor of Psychiatry, Université Paris-Est Créteil; CEO Fondation FondaMental; PEPR Propsy; Director, Translational NeuroPsychiatry laboratory, Inserm U955
“Goal of the Symposium & Presentation of the French Program in Precision Psychiatry PEPR PROPSY”
ISRAEL
Dr. Jordan Lewinski — Head of Mental Health Services, Clalit Health Services
09:15 – 10:15 PRECISION PSYCHIATRY: PATIENT STRATIFICATION & TARGETED TREATMENTS
Immuno-Psychiatry: Towards New Treatment Targets
Moderator: Prof. Marion Leboyer, Université Paris-Est Créteil; CEO Fondation FondaMental; PEPR Propsy
ISRAEL
Prof. Michal Schwartz — Weizmann Institute of Science
“Towards new targets in Immuno-Psychiatry”
FRANCE
Prof. Laurent Groc — CNRS, Bordeaux
“Autoimmunity in neuropsychiatry: from molecule to patients”
Prof. David Klatzmann — Inserm & IL TOO, Paris
“Autism as a reversible neuroimmune condition: from experimental mouse models to clinical case reports”
10:15 – 10:45 Coffee Break
10:45 – 12:15 New Digital Tools & AI Towards Precision Psychiatry
Moderator: Dr. Eyal Erook — Head of AI Practice, S. Horowitz.
ISRAEL
Prof. Noam Shomron — Tel Aviv University
“AI in Genomics”
Dr. Orit Goldman — VP Biology, NeuroKaire
“New tools for patient stratification and drug discovery”
FRANCE
Léah Camarat & Andrij Kulakovskyi — Fondation FondaMental
“AI and mental health”
Daniel Szeftel — CEO, Semeia
“Telemonitoring in mental health disorders”
Dinah Weissmann — CSO, Alcediag
“RNA editing biomarker blood test for the diagnosis of bipolar disorder”
12:15 – 13:30 Lunch
13:30 – 15:00 New Therapeutics Towards Precision Psychiatry
Moderator: Dr. Anna Elgart, Teva Pharmaceuticals
ISRAEL
Prof. Amir Krivoy — Geha Mental Health Center · Chair, Israel Society for Biological Psychiatry (ISBP)
“Metabolic Psychiatry – new targets for diagnosis and treatment”
Prof. Ilana Gozes — Tel Aviv University
“Novel approaches to autism, from de novo mutated genes to future innovative therapeutics”
Elisabeth Kogan — CEO, Syneris
“New targets in psychiatry”
Dr. Eran Harary — CMO, Remepy
FRANCE/ISRAEL
Prof. Marion Leboyer & Prof. Jonathan Javitt — CEO, NRX Pharmaceuticals
Prof. Marion Leboyer & Prof. Mark Weiser — Sheba Medical Center
“New therapies in schizophrenia” - Lancet Schizophrenia Consortium
15:00 – 16:00 Neuromodulation Towards Precision Psychiatry
ISRAEL
Prof. Yair Bar-Haim — Tel Aviv University · Director, National Center for Traumatic Stress and Resilience
“Targeted Neuromodulation of the Hippocampal Network to reduce intrusive memories in PTSD”
Prof. Abraham Zangen, Board Director Brainsway. Head of the Brain Stimulation and Behavior Lab and Chair of the Psychology Brain Program at Ben Gurion University of the Negev.
FRANCE
Prof. Mircea Polosan — Grenoble Alpes University, Head of the Adult Psychiatry Department – CHU Grenoble Alpes / INSERM – Brain, Behavior and Neuromodulation “DBS in OCD: from brain networks to personalized therapy”
Jeremy Bercoff — CEO, Sonomind
“Ultrasound in mental disorders”
16:00 – 17:00 PTSD Clinical Excellence: French–Israeli Perspectives on Hospital Psychiatry and the Care Pathway
Moderator: Gila Tolub, CEO ICAR Collective
ISRAEL
Dr. Keren Avirame — Tel Aviv Sourasky Medical Center Prof. Asher Ben-Arieh — Hebrew University
“Peace of Mind platform”
FRANCE
Prof. Denis Peschanski — CNRS Dr. Amaury Mengin – Strasbourg University Hospital, Grand Est Regional Psychotrauma Center
“Novelties and challenges in PTSD treatment”
17:00 – 18:00 B2B – Building Collaborative Projects per Domain
Immunology · Digital tools & AI · New treatment targets · Neuromodulation
17:00–17:30 Group meetings
17:30–18:00 Restitution of projects per domain
18:00 Conclusion of the Meeting